• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VCL+ VIO 8X18IN 3-0 S/A RB-1 CR; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VCL+ VIO 8X18IN 3-0 S/A RB-1 CR; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Catalog Number VCP713D
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/28/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint # (b)(4).H6 component code: g07002 - device not returned.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, and the following was obtained via: additional information in note a-12039138 states that 7 products are involved; however, it also states that about half of (b)(4) sutures of the package were broken.Please clarify: how many sutures were broken? half of (b)(4) strands in a pac broke.Also, the actual samples are (b)(4) pacs.What is the lot number of each broken suture (101rgs, 1022q1, 101gx2, other)? unk.When did each suture break (in the package, during removal from package, during handling prior to use on patient or during use on the patient)? please specify.During use on the patient.Please perform and document the follow up attempt for product return.Please document the shipment tracking number in notes or rmao sections.The device has been received at sukagawa and will be shipped.Please check rmao.Tracking number: (b)(4).Please provide the source or name and title of external person providing answers to follow-up (external person submitting answers to sales rep or loc/bq).(b)(6).We got this info from the sales-rep on nov_1_2024.Qty to be returned of (b)(4): 0 => (b)(4) (lot#: 101rgs).Qty of product involved of (b)(4): (b)(4) (lot#: 101rgs x2packs, 1022q1 x4packs, 101gx2 x1pack).Additional event information: english: about half of the (b)(4) sutures of the package were broken when tried to ligate.One package will be returned with the same lot number of sutures as the lot number: 101rgs of the product involved.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.D4: full udi currently unavailable since the exact lot of the suspected device cannot be determined.
 
Event or Problem Description
It was reported that a patient underwent an unknown neurosurgery procedure on (b)(6) 2024 and suture was used.During the procedure, it was reported by a sales rep that, during closing the head, it was tried to suture and then ligate, but the suture was broken.Details are being confirmed.It was a control release needle.No adverse patient consequences were reported.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 2/21/2025.Corrected information: d4 udi.Additional information: h6.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VCL+ VIO 8X18IN 3-0 S/A RB-1 CR
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
calle durango #2751
ciudad juarez 32575
MX   32575
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key20788975
Report Number2210968-2024-12531
Device Sequence Number7895208
Product Code GAM
UDI-Device Identifier10705031054998
UDI-Public(01)10705031054998(17)290531(10)101RGS
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
K032420
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberVCP713D
Device Lot Number101RGS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/29/2024
Supplement Date Received by Manufacturer01/24/2025
Initial Report FDA Received Date11/26/2024
Supplement Report FDA Received Date02/21/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-